Business profile
Indian pharmaceutical company selling branded medicines across chronic and acute therapies, plus consumer health products.
SectorPharma
CountryIndia
Listed onNSE, BSE
Latest quarterQ2 FY27
Latest results · Q2 FY27
Revenue₹4,432.71 cr
+17.0% YoY
Net profit₹711.48 cr
+39.1% YoY
Quarterly results
| ₹ crore | Q2 FY26 | Q2 FY27 |
|---|---|---|
| Revenue | ~3,789 | 4,433 |
| Net profit | ~511 | 711 |
| Profit margin | ~13.5% | 16.1% |
| Revenue growth YoY | — | +17.0% |
| Profit growth YoY | — | +39.1% |
~ approximate: worked out from the reported year-on-year growth, not a reported figure.
OneTrader reports
- Top Q2 Earnings Today: Tata Consumer, Mankind Pharma, REC and More
- Sensex, Nifty Closing Today, October 27, 2026: Sensex Ends Flat, Nifty Below 22,750 as IT and Banking Stocks Weigh
- Stock Market Today, October 16, 2026: Nifty, Sensex, Top Stocks and Major News
- Stocks to Watch Today: Shiprocket, Adani Power, LIC, HDFC Life and More
- How to Build a 10-Year Stock Portfolio from Scratch (2025 Guide)
More in Pharma
Anlon HealthcareCiplaDr Reddy's LaboratoriesGland PharmaMorepen LaboratoriesOneSource Specialty PharmaPiramal Pharma
India figures in ₹ crore. YoY = change versus the same quarter last year. Figures are taken from company results as reported in OneTrader articles. For information only, not investment advice.